Abstract
Transforming growth factor beta (TGF-beta) is a potent chemoattractant in vitro for human dermal fibroblasts. Intact disulfide and perhaps the dimeric structure of TGF-beta is essential for its ability to stimulate chemotactic migration of fibroblasts, since reduction with 2-ME results in a marked loss of its potency as a chemoattractant. Although epidermal growth factor (EGF) appears to be capable of modulating some effects of TGF-beta, it does not alter the chemotactic response of fibroblasts to TGF-beta. Specific polyvalent rabbit antibodies to homogeneously pure TGF-beta block its chemotactic activity but has no effect on the other chemoattractants tested (platelet-derived growth factor, fibronectin, and denatured type I collagen). Since TGF-beta is secreted by a variety of neoplastic and normal cells including platelets, monocytes/macrophages, and lymphocytes, it may play a critical role in vivo in embryogenesis, host response to tumors, and the repair response that follows damage to tissues by immune and nonimmune reactions.
MeSH Terms
Blood Platelets/analysis
Chemotaxis/drug effects
Epidermal Growth Factor/pharmacology
Fibroblasts/physiology
Humans
Peptides/pharmacology
Transforming Growth Factors
Chemicals
Peptides
Epidermal Growth Factor
Transforming Growth Factors
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Postlethwaite A E
Keski-Oja J
Moses H L
Kang A H
References (14)
14 references, click to expand
-
Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.
J Exp Med. 1973 Feb 1;137(2):387-410
PMID: 4568301
-
Collagen-and collagen peptide-induced chemotaxis of human blood monocytes.
J Exp Med. 1976 Jun 1;143(6):1299-307
PMID: 1271012
-
Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment.
J Exp Med. 1981 Feb 1;153(2):494-9
PMID: 7241050
-
Transforming growth factor production by chemically transformed cells.
Cancer Res. 1981 Jul;41(7):2842-8
PMID: 6265069
-
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.
J Biol Chem. 1983 Jun 10;258(11):7155-60
PMID: 6602130
-
Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.
Proc Natl Acad Sci U S A. 1984 Nov;81(21):6757-61
PMID: 6208555
-
Type beta transforming growth factor: a bifunctional regulator of cellular growth.
Proc Natl Acad Sci U S A. 1985 Jan;82(1):119-23
PMID: 3871521
-
Platelet-derived growth factor-induced alterations in vinculin and actin distribution in BALB/c-3T3 cells.
J Cell Biol. 1985 Apr;100(4):1031-40
PMID: 3920222
-
Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells.
Nature. 1985 Aug 22-28;316(6030):701-5
PMID: 3861940
-
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.
J Biol Chem. 1986 Mar 25;261(9):4337-45
PMID: 3456347
-
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.
J Exp Med. 1986 May 1;163(5):1037-50
PMID: 2871125
-
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.
Proc Natl Acad Sci U S A. 1986 Jun;83(12):4167-71
PMID: 2424019
-
Cellular distribution of type I and type II receptors for transforming growth factor-beta.
J Biol Chem. 1986 Jul 25;261(21):9972-8
PMID: 2874135
-
Peptide growth factors and inflammation, tissue repair, and cancer.
J Clin Invest. 1986 Aug;78(2):329-32
PMID: 3525608